secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001860742-24-000011
Event type: earnings
Sentiment:  negative
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q2 revenue $1.216B (+17% YoY); GAAP net loss $151M; raises FY2024 guidance
--------------------------------------------------------------------------------

- Revenue $1.216B, up 17% reported and 20% constant currency vs Q2 2023.
- GAAP net loss attributable to BLCO $151M; adjusted EPS $0.13 (vs $0.18 a year ago).
- Pharmaceuticals segment revenue surged 60% YoY to $310M, driven by XIIDRA acquisition and MIEBO launch.
- Raised FY2024 revenue guidance to $4.7-4.8B (prev $4.6-4.7B) and adjusted EBITDA to $850-900M.
- Adjusted EBITDA (non-GAAP) $209M, up from $179M in Q2 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074224000011/0001860742-24-000011-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074224000011/blco-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001860742-24-000011

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer